Transgene Biotek Ltd. - Research Center
526139 TRABI Group (XT) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 0.06 | 0.09 | - | - | - |
| Operating profit | -0.68 | -0.22 | -0.25 | -0.32 | -0.43 |
| Interest | 0.09 | 0.11 | 0.11 | 0.13 | 0.15 |
| Gross profit | -0.68 | -0.20 | -0.27 | -0.36 | -0.50 |
| EPS (Rs) | -0.42 | -0.68 | -0.69 | -0.70 | -0.72 |
Half yearly
results in details
| Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 0.09 | 0.12 | 0.09 | 0.09 | 0.08 |
| Stock adjustment | - | -0.07 | - | - | - |
| Raw material | - | 0.02 | 0.01 | 0.01 | -0.03 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.15 | 0.16 | 0.13 | 0.15 | 0.14 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 0.58 | 0.20 | 0.11 | 0.15 | 0.32 |
| Provisions made | - | - | - | - | - |
| Depreciation | 2.48 | 4.98 | 4.94 | 4.95 | 4.95 |
| Taxation | - | - | - | - | - |
| Net profit / loss | -3.16 | -5.19 | -5.21 | -5.31 | -5.45 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -1233.73 | -254.23 | -14591.29 | - | -12128.77 |
| GPM (%) | -478.07 | -97.52 | -305.41 | - | -569.98 |
| NPM (%) | -2211.68 | -2472.36 | -5832.99 | - | -6212.85 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis